EAM
CLB icon

Eukles Asset Management’s Core Laboratories CLB Stock Holding History

Eukles Asset Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-453
Closed -$27K – 152
2018
Q4 		$27K Buy
+453
New +$39.1K 0.03% 106

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Eukles Asset Management's CLB Position: Q1 2019 in Review

Eukles Asset Management sold out of Core Laboratories (CLB) in Q1 2019, closing a stake of 453 shares — an estimated $27K sold.

Eukles Asset Management first reported a position in CLB in Q4 2018 and held it in 1 quarter. The position peaked at $27K in Q4 2018. 313 funds tracked by Wall St. Rank hold CLB as of Q1 2019.

  • Eukles Asset Management reported no remaining Core Laboratories position as of Q1 2019 after selling out during the quarter.
  • Eukles Asset Management sold 453 Core Laboratories shares in Q1 2019, an estimated $27K.
  • Eukles Asset Management first reported a position in Core Laboratories in Q4 2018 and held it in 1 quarter.
  • Eukles Asset Management's Core Laboratories position peaked at $27K in Q4 2018.
  • 313 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2019.

Based on Eukles Asset Management's 13F filing for Q1 2019, filed 23 Apr 2019.